Omnicare, Inc. v. Laborers Dist. Council Constr. Industry Pension Fund

575 U.S. 175, 135 S. Ct. 1318, 191 L. Ed. 2d 253, 25 Fla. L. Weekly Fed. S 139, 2015 U.S. LEXIS 2120, 83 U.S.L.W. 4187
CourtSupreme Court of the United States
DecidedMarch 24, 2015
Docket13–435.
StatusPublished
Cited by503 cases

This text of 575 U.S. 175 (Omnicare, Inc. v. Laborers Dist. Council Constr. Industry Pension Fund) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Omnicare, Inc. v. Laborers Dist. Council Constr. Industry Pension Fund, 575 U.S. 175, 135 S. Ct. 1318, 191 L. Ed. 2d 253, 25 Fla. L. Weekly Fed. S 139, 2015 U.S. LEXIS 2120, 83 U.S.L.W. 4187 (2015).

Opinion

Opinion *1323 Justice KAGANdelivered the opinion of the Court.

Before a company may sell securities in interstate commerce, it must file a registration statement with the Securities and Exchange Commission (SEC). If that document either "contain[s] an untrue statement of a material fact" or "omit[s] to state a material fact ... necessary to make the statements therein not misleading," a purchaser of the stock may sue for damages. 15 U.S.C. § 77k(a). This case requires us to decide how each of those phrases applies to statements of opinion.

I

The Securities Act of 1933, 48 Stat. 74 , 15 U.S.C. § 77a et seq., protects investors by ensuring that companies issuing securities (known as "issuers") make a "full and fair disclosure of information" relevant to a public offering. Pinter v. Dahl, 486 U.S. 622 , 646, 108 S.Ct. 2063 , 100 L.Ed.2d 658 (1988). The linchpin of the Act is its registration requirement. With limited exceptions not relevant here, an issuer may offer securities to the public only after filing a registration statement. See §§ 77d, 77e. That statement must contain specified information about both the company itself and the security for sale. See §§ 77g, 77aa. Beyond those required disclosures, the issuer may include additional representations of either fact or opinion.

Section 11 of the Act promotes compliance with these disclosure provisions by giving purchasers a right of action against an issuer or designated individuals (directors, partners, underwriters, and so forth) for material misstatements or omissions in registration statements. As relevant here, that section provides:

"In case any part of the registration statement, when such part became effective, contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading, any person acquiring such security ... [may] sue." § 77k(a).

Section 11 thus creates two ways to hold issuers liable for the contents of a registration statement-one focusing on what the statement says and the other on what it leaves out. Either way, the buyer need not prove (as he must to establish certain other securities offenses) that the defendant acted with any intent to deceive or defraud. Herman & MacLean v. Huddleston, 459 U.S. 375 , 381-382, 103 S.Ct. 683 , 74 L.Ed.2d 548 (1983).

This case arises out of a registration statement that petitioner Omnicare filed in connection with a public offering of common stock. Omnicare is the nation's largest provider of pharmacy services for residents of nursing homes. Its registration statement contained (along with all mandated disclosures) analysis of the effects of various federal and state laws on its business model, including its acceptance of rebates from pharmaceutical manufacturers. See, e.g., App. 88-107, 132-140, 154-166. Of significance here, two sentences in the registration statement expressed Omnicare's view of its compliance with legal requirements:

• "We believe our contract arrangements with other healthcare providers, our pharmaceutical suppliers and our pharmacy practices are in compliance with applicable federal and state laws." Id., at 95.
• "We believe that our contracts with pharmaceutical manufacturers are legally and economically valid arrangements that bring value to the healthcare system and the patients that we serve." Id., at 137.

*1324 Accompanying those legal opinions were some caveats. On the same page as the first statement above, Omnicare mentioned several state-initiated "enforcement actions against pharmaceutical manufacturers" for offering payments to pharmacies that dispensed their products; it then cautioned that the laws relating to that practice might "be interpreted in the future in a manner inconsistent with our interpretation and application." Id., at 96. And adjacent to the second statement, Omnicare noted that the Federal Government had expressed "significant concerns" about some manufacturers' rebates to pharmacies and warned that business might suffer "if these price concessions were no longer provided." Id., at 136-137.

Respondents here, pension funds that purchased Omnicare stock in the public offering (hereinafter Funds), brought suit alleging that the company's two opinion statements about legal compliance give rise to liability under § 11. Citing lawsuits that the Federal Government later pressed against Omnicare, the Funds' complaint maintained that the company's receipt of payments from drug manufacturers violated anti-kickback laws. See id., at 181-186, 203-226. Accordingly, the complaint asserted, Omnicare made "materially false" representations about legal compliance. Id., at 274. And so too, the complaint continued, the company "omitted to state [material] facts necessary" to make its representations not misleading. Id., at 273. The Funds claimed that none of Omnicare's officers and directors "possessed reasonable grounds" for thinking that the opinions offered were truthful and complete. Id., at 274. Indeed, the complaint noted that one of Omnicare's attorneys had warned that a particular contract "carrie[d] a heightened risk" of liability under anti-kickback laws. Id., at 225 (emphasis deleted). At the same time, the Funds made clear that in light of § 11's strict liability standard, they chose to "exclude and disclaim any allegation that could be construed as alleging fraud or intentional or reckless misconduct." Id., at 273.

The District Court granted Omnicare's motion to dismiss. See Civ. No. 2006-26 (ED Ky., Feb. 13, 2012), App. to Pet. for Cert. 28a, 38a-40a, 2012 WL 462551 , *4-*5.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Camelot Event Driven Fund v. Morgan Stanley & Co., LLC
2024 NY Slip Op 01866 (Appellate Division of the Supreme Court of New York, 2024)
Waters v. Pumphrey
Court of Appeals of North Carolina, 2022
Ponsa-Rabell v. Santander Securities, LLC
35 F.4th 26 (First Circuit, 2022)
Jarkesy v. SEC
34 F.4th 446 (Fifth Circuit, 2022)
Wong v. Restoration Robotics
California Court of Appeal, 2022
SEC v. GenAudio Inc.
32 F.4th 902 (Tenth Circuit, 2022)
Robert Lowinger, V. Funko, Inc.
Court of Appeals of Washington, 2021
IWA Forest Industry Pension Plan v. Textron Inc.
14 F.4th 141 (Second Circuit, 2021)
John Golub v. Gigamon Inc.
Ninth Circuit, 2021
Cho v. BlackBerry Ltd.
991 F.3d 155 (Second Circuit, 2021)
Labourers' Pension Fund of Cent. & E. Can. v. CVS Health Corp.
2021 NY Slip Op 01327 (Appellate Division of the Supreme Court of New York, 2021)
In Re General Electric
Second Circuit, 2021
Yan v. ReWalk Robotics Ltd.
973 F.3d 22 (First Circuit, 2020)
Leonard Panella v. Tesco Corporation
971 F.3d 475 (Fifth Circuit, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
575 U.S. 175, 135 S. Ct. 1318, 191 L. Ed. 2d 253, 25 Fla. L. Weekly Fed. S 139, 2015 U.S. LEXIS 2120, 83 U.S.L.W. 4187, Counsel Stack Legal Research, https://law.counselstack.com/opinion/omnicare-inc-v-laborers-dist-council-constr-industry-pension-fund-scotus-2015.